Paget–Schroetter disease
Paget–Schroetter disease (also known as effort thrombosis or Paget-von Schrötter disease) is a form of thrombosis in the upper extremity, causing blood clots in the deep veins of the arms. It is a rare condition, typically affecting young, active individuals.
Causes[edit | edit source]
The exact cause of Paget–Schroetter disease is unknown, but it is believed to be due to a combination of anatomical abnormalities and repetitive arm movements, which can lead to damage to the veins. This damage can cause blood clots to form, leading to the symptoms of the disease.
Symptoms[edit | edit source]
The symptoms of Paget–Schroetter disease can vary, but often include pain, swelling, and discoloration in the affected arm. Other symptoms can include a heavy feeling in the arm, weakness, and sometimes shortness of breath.
Diagnosis[edit | edit source]
Diagnosis of Paget–Schroetter disease is typically made through a combination of medical history, physical examination, and imaging tests such as ultrasound or magnetic resonance imaging (MRI). Blood tests may also be used to check for blood clotting disorders.
Treatment[edit | edit source]
Treatment for Paget–Schroetter disease typically involves anticoagulation therapy to prevent further blood clots from forming. In some cases, thrombolysis may be used to break up existing clots. Surgery may also be considered in some cases to remove the clot and correct any underlying anatomical abnormalities.
Prognosis[edit | edit source]
With appropriate treatment, the prognosis for Paget–Schroetter disease is generally good. However, it is important to seek medical attention promptly if symptoms occur, as untreated blood clots can lead to serious complications such as pulmonary embolism.
See also[edit | edit source]
Paget–Schroetter disease Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD